Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 37
2013 149
2014 148
2015 141
2016 125
2017 162
2018 121
2019 132
2020 143
2021 166
2022 136
2023 117
2024 158
2025 173
2026 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,481 results

Results by year

Filters applied: . Clear all
Page 1
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS.
Salomon-Zimri S, Pushett A, Russek-Blum N, Van Eijk RPA, Birman N, Abramovich B, Eitan E, Elgrart K, Beaulieu D, Ennist DL, Berry JD, Paganoni S, Shefner JM, Drory VE. Salomon-Zimri S, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 May;24(3-4):263-271. doi: 10.1080/21678421.2022.2119868. Epub 2022 Sep 15. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36106817 Free article. Clinical Trial.
Prevalence of amyotrophic lateral sclerosis in the United States, 2018.
Mehta P, Raymond J, Zhang Y, Punjani R, Han M, Larson T, Muravov O, Lyles RH, Horton DK. Mehta P, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug 21:1-7. doi: 10.1080/21678421.2023.2245858. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37602649 Free article.
ALSUntangled #72: Insulin.
Brown A, Armon C, Barkhaus P, Beauchamp M, Bertorini T, Bromberg M, Cadavid JM, Carter GT, Crayle J, Feldman EL, Heiman-Patterson T, Jhooty S, Linares A, Li X, Mallon E, Mcdermott C, Mushannen T, Nathaniel G, Pattee G, Pierce K, Ratner D, Slactova L, Wicks P, Bedlack R. Brown A, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):416-419. doi: 10.1080/21678421.2023.2288110. Epub 2023 Nov 28. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38018119 Review.
Occupational lead exposure and survival with amyotrophic lateral sclerosis.
Wang TW, Wuu J, Cooley A, Yeh TS, Benatar M, Weisskopf M. Wang TW, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):100-107. doi: 10.1080/21678421.2022.2059379. Epub 2022 Apr 9. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35400246 Free PMC article.
ALSUntangled #61: melatonin.
ALSUNTANGLED GROUP. ALSUNTANGLED GROUP. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):157-160. doi: 10.1080/21678421.2021.1927103. Epub 2021 May 18. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 34002641 Review.
1,481 results